Research Topics
| F CentorrinoSummaryAffiliation: Harvard Medical School Country: USA Publications
|
Detail Information
Publications
EEG abnormalities during treatment with typical and atypical antipsychoticsFranca Centorrino
Bipolar and Psychotic Disorder Program, McLean Hospital, MA 02478, USA
Am J Psychiatry 159:109-15. 2002..Much less is known about EEG effects of newer antipsychotics. The present study therefore examined the risk of EEG abnormalities associated with various antipsychotic drugs...- Antipsychotic drug use: McLean Hospital, 2002Franca Centorrino
Department of Psychiatry and Neuroscience Program, Harvard Medical School, Boston, USA
Hum Psychopharmacol 20:355-8. 2005..Major changes in antipsychotic treatment in recent years encouraged a survey of inpatient practice in 2002, compared with earlier samples... - Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefitsFranca Centorrino
Department of Psychiatry and Neuroscience Program, Harvard Medical School and Bipolar and Psychotic Disorders Clinic, McLean Hospital, Boston, MA USA
Am J Psychiatry 161:700-6. 2004.... - Oxcarbazepine: clinical experience with hospitalized psychiatric patientsFranca Centorrino
Consolidated Department of Psychiatry, Harvard Medical School, Boston, MA, USA
Bipolar Disord 5:370-4. 2003.... - Delirium during clozapine treatment: incidence and associated risk factorsF Centorrino
Department of Psychiatry and Neuroscience Program, Harvard Medical School, Boston, MA, USA
Pharmacopsychiatry 36:156-60. 2003..Incidence and risk factors for delirium during clozapine treatment require further clarification... - Pilot comparison of extended-release and standard preparations of divalproex sodium in patients with bipolar and schizoaffective disordersFranca Centorrino
Department of Psychiatry, Harvard Medical School, Boston, USA
Am J Psychiatry 160:1348-50. 2003..The authors compared the new extended-release and standard preparations of divalproex sodium... - Inpatient antipsychotic drug use in 1998, 1993, and 1989Franca Centorrino
Department of Psychiatry and Neuroscience Program, Harvard Medical School, Boston, MA 02478 9106, USA
Am J Psychiatry 159:1932-5. 2002..Patterns of clinical use of antipsychotic agents have changed greatly in the past decade. The authors' goal was to examine these patterns... 
Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004Franca Centorrino
Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA
Hum Psychopharmacol 25:179-86. 2010..We tested the hypothesis that combinations and total daily doses of psychotropics for hospitalized patients diagnosed with major psychiatric disorders are rising...- Use of combinations of antipsychotics: McLean Hospital inpatients, 2002Franca Centorrino
Department of Psychiatry and Neuroscience Program, Harvard Medical School, Boston, MA 02478-9106, USA
Hum Psychopharmacol 20:485-92. 2005.... - Weight loss in overweight patients maintained on atypical antipsychotic agentsF Centorrino
Consolidated Department of Psychiatry, McLean Hospital, Harvard Medical School, Boston, MA, USA
Int J Obes (Lond) 30:1011-6. 2006..Weight gain and associated medical morbidity offset the reduction of extrapyramidal side effects associated with atypical antipsychotics. Efforts to control weight in antipsychotic-treated patients have yielded limited success... - Comorbid substance-use in schizophrenia: relation to positive and negative symptomsA Talamo
Department of Psychiatry, Harvard Medical School, Boston, MA, USA
Schizophr Res 86:251-5. 2006..Comorbid SUD in schizophrenia patients was associated with male sex and higher PANSS positive to lower negative scores. Cause-effect relationships remain to be clarified... 
Comparison of mania patients suitable for treatment trials versus clinical treatmentAlessandra Talamo
Department of Psychiatry and Neuroscience Program, Harvard Medical School, Boston, Massachusetts, USA
Hum Psychopharmacol 23:447-54. 2008..The pilot study is limited in numbers and exposure times with which to test for the minor differences between "research subjects" and "clinical patients."..- An observational study of the effectiveness and safety of intramuscular olanzapine in the treatment of acute agitation in patients with bipolar mania or schizophrenia/schizoaffective disorderFranca Centorrino
McLean Hospital, Harvard Medical School, Boston, MA, USA
Hum Psychopharmacol 22:455-62. 2007..To determine the effect of intramuscular (IM) olanzapine in severely agitated patients... - Hospital use of antipsychotic drugs: polytherapyFranca Centorrino
Department of Psychiatry and Neuroscience Program, Harvard Medical School, Boston, MA 02115, USA
Compr Psychiatry 49:65-9. 2008..Growing acceptance of new psychotropic drugs encouraged a survey of current use of antipsychotic drugs alone and in combinations, with comparisons with previous findings... - Clinical outcome in patients with bipolar I disorder, obsessive compulsive disorder or bothFranca Centorrino
Schizophrenia and Bipolar Disorder Program, McLean Hospital, Belmont 02478, and Department of Psychiatry, Harvard Medical School, Cambridge, MA, USA
Hum Psychopharmacol 21:189-93. 2006..Bipolar disorder (BPD) is often comorbid with obsessive-compulsive (OCD) and other anxiety disorders, but the impact of such comorbidity on long-term outcome has not been evaluated systematically... - Ziprasidone: first year experience in a hospital settingFranca Centorrino
Schizophrenia and Bipolar Disorder Clinic, McLean Hospital, Belmont, MA 02478-9106, USA
J Psychiatr Pract 10:361-7. 2004..CONCLUSIONS: Ziprasidone was well tolerated by hospitalized patients with various major psychiatric disorders and may be of value in conditions other than schizophrenia... - Advances in atypical antipsychotics for the treatment of schizophrenia: new formulations and new agentsJames P Kelleher
Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA
CNS Drugs 16:249-61. 2002..These new formulations and agents should broaden options for the treatment of psychosis... - Lithium treatment reduces suicide risk in recurrent major depressive disorderFrancesca Guzzetta
Department of Psychiatry, Harvard Medical School, Boston, MA, USA
J Clin Psychiatry 68:380-3. 2007..Since lithium shows major antisuicidal effects in bipolar disorders and in heterogeneous mood disorder samples, we evaluated evidence of antisuicidal effects of lithium in patients with recurrent MDD... - Health and economic burden of metabolic comorbidity among individuals with bipolar disorderFranca Centorrino
Schizophrenia Bipolar Disorder and Psychopharmacology Programs, McLean Division of Massachusetts General Hospital, Belmont, MA 02478, USA
J Clin Psychopharmacol 29:595-600. 2009..To compare the prevalence and health care costs of metabolic conditions in patients with bipolar disorder to age- and sex-matched control patients using a large insurance claims database... - Weygandt's On the Mixed States of Manic-Depressive Insanity: a translation and commentary on its significance in the evolution of the concept of bipolar disorderPaola Salvatore
Department of Psychiatry and the Neuroscience Program, Harvard Medical School, Boston, Mass, USA
Harv Rev Psychiatry 10:255-75. 2002.... - Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depressionMauricio Tohen
Lilly Research Laboratories, Indianapolis, IN 46285, USA
Arch Gen Psychiatry 60:1079-88. 2003.... - Aripiprazole: initial clinical experience with 142 hospitalized psychiatric patientsFranca Centorrino
Harvard Medical School and McLean Hospital, Belmont, MA 02478-9106, USA
J Psychiatr Pract 11:241-7. 2005..Since aripiprazole is likely to be considered for obese patients, body weight should be considered in establishing adequate doses. Controlled trials of this antipsychotic agent in disorders other than schizophrenia are needed... - Clinical comparison of extended-release divalproex versus delayed-release divalproex: pooled data analyses from nine trialsMichael C Smith
Rush Epilepsy Center, Rush Presbyterian St Luke s Medical Center, Chicago, IL, USA
Epilepsy Behav 5:746-51. 2004..Although the results of the current analyses must be considered highly tentative due to the open-label nature of the trials included, the findings do suggest broad clinical superiority of the new ER preparation...